# SKYE (Skye Bioscience, Inc.) - SEC EDGAR Financial Statements

> Skye Bioscience, Inc. reported $5.07M in total assets and a net loss of $37.67M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/SKYE
- Markdown: https://convexityos.com/fundamentals/SKYE.md
- SEC CIK: 0001516551
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001516551&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$38.60M | Operating profit |
| Net Income | FY 2025 | -$37.67M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$7.54 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$30.58M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $4.82M | Total debt: $9.5K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $42.36M | $18.70M | $5.82M | $6.01M | $2.93M | $1.94M | $2.24M | $330K | $311K | $939K |
| Total Operating Expenses | $58.16M | $30.19M | $34.74M | $18.31M | $7.85M | $6.29M | $6.63M | $4.69M | $3.86M | $4.47M |
| **Operating Income** | -$58.16M | -$30.19M | -$34.74M | -$18.31M | -$7.85M | -$6.29M | -$6.63M | -$4.69M | -$3.86M | -$4.47M |
| **EBITDA** | -$57.44M | -$29.89M | -$34.61M | -$18.20M | -$7.81M | -$6.29M | -$6.63M | -$4.69M | -$3.85M | -$4.46M |
| Interest Income | $1.88M | $3.03M | $100K | $19K | $3 | $29 | $26 | $84 | -- | -- |
| Interest Expense | $0 | $749K | $906K | $665K | $769K | $706K | $1.00M | $95K | $667 | -- |
| Income Before Tax | -$55.92M | -$26.56M | -$37.64M | -$19.47M | -$8.52M | -$6.56M | $1.05M | -$19.19M | -$3.09M | -$3.18M |
| Income Tax Expense | $5.4K | $10K | $3.6K | $6.7K | $2.1K | $1.6K | $1.6K | $1.6K | $1.6K | $1.6K |
| **Net Income** | -$55.92M | -$26.57M | -$37.64M | -$19.48M | -$8.52M | -$6.56M | $1.05M | -$19.19M | -$3.09M | -$3.18M |
| Basic EPS | -$11.28 | -$5.84 | -$42.96 | -$70.16 | -$40.00 | -$60.00 | $20.00 | -$320.00 | -$220.00 | -$340.00 |
| **Diluted EPS** | -$11.28 | -$5.84 | -$42.96 | -$70.16 | -$40.00 | -$60.00 | -$100.00 | -$320.00 | -$220.00 | -$340.00 |
| Basic Shares Outstanding | 5.0M | 4.6M | 875.8K | 277.6K | 203.3K | 115.4K | 67.6K | 60.6K | 14.0K | 9.5K |
| Diluted Shares Outstanding | 5.0M | 4.6M | 875.8K | 277.6K | 203.3K | 115.7K | 84.8K | 60.6K | 14.0K | 9.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.32M | $3.94M | $7.94M | $11.47M | $9.36M | $14.34M | $7.20M | $7.79M |
| Total Operating Expenses | -$26K | $11.06M | $12.67M | $14.90M | $13.26M | $18.24M | $11.76M | $10.67M |
| **Operating Income** | $26K | -$11.06M | -$12.67M | -$14.90M | -$13.26M | -$18.24M | -$11.76M | -$10.67M |
| **EBITDA** | $58K | -$10.90M | -$12.50M | -$14.72M | -$13.09M | -$18.06M | -$11.58M | -$10.49M |
| Interest Income | $49K | $103K | $170K | $274K | $418K | $533K | $619K | $732K |
| Interest Expense | $3.3K | $3.3K | $2.2K | $0 | $0 | $0 | $1.5K | -$47K |
| Income Before Tax | $69K | -$10.78M | -$12.51M | -$14.44M | -$12.75M | -$17.62M | -$11.10M | -$9.75M |
| Income Tax Expense | $0 | $3.4K | $0 | $0 | $0 | $3.4K | $2.0K | $0 |
| **Net Income** | $69K | -$10.79M | -$12.51M | -$14.44M | -$12.75M | -$17.62M | -$11.10M | -$9.75M |
| Basic EPS | $0.01 | -$2.16 | -$2.56 | -- | -$2.57 | -$3.52 | -$2.24 | -- |
| **Diluted EPS** | $0.01 | -$2.16 | -$2.56 | -- | -$2.57 | -$3.52 | -$2.24 | -- |
| Basic Shares Outstanding | 5.0M | 5.0M | 5.0M | -- | 5.0M | 5.0M | 5.0M | -- |
| Diluted Shares Outstanding | 5.0M | 5.0M | 5.0M | -- | 5.0M | 5.0M | 5.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.88M | $68.42M | $1.26M | $1.24M | $8.98M | $2.47M | $1.83M | $1.85M | $260K | $65K |
| Short-Term Investments | $19.85M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $25.74M | $68.42M | $1.26M | $26K | $8.98M | $2.47M | $1.83M | $1.85M | $260K | $65K |
| Other Current Assets | $852K | $2.21M | $1.12M | $482K | $57K | $275 | $7.5K | $2.6K | -- | $7.0K |
| **Total Current Assets** | $27.09M | $70.83M | $11.65M | $8.94M | $9.61M | $2.66M | $1.99M | $1.95M | $556K | $279K |
| Property, Plant & Equipment, Net | $899K | $1.43M | $43K | $88K | $88K | $7.3K | $2.0K | $3.4K | $1.4K | $9.6K |
| Other Non-Current Assets | $54K | $54K | $8.3K | $8.3K | $8.3K | $0 | -- | -- | -- | $34K |
| **Total Non-Current Assets** | $1.22M | $1.94M | $290K | $167K | $243K | $7.3K | $2.0K | $3.4K | $1.4K | $44K |
| **Total Assets** | $28.31M | $72.76M | $11.94M | $9.11M | $9.86M | $2.67M | $2.00M | $1.96M | $557K | $323K |
| Accounts Payable | $2.03M | $569K | $1.16M | $1.67M | $898K | $364K | $130K | $16K | $101K | $275K |
| Other Current Liabilities | $2.64M | $654K | $999K | $1.37M | $376K | $198K | $420K | $184K | -- | -- |
| **Total Current Liabilities** | $8.21M | $4.34M | $13.90M | $12.12M | $3.91M | $787K | $971K | $15.94M | $806K | $662K |
| **Total Non-Current Liabilities** | $84K | $273K | $171K | $0 | $79K | $1.43M | $478K | $1.58M | $551K | $1.11M |
| **Total Liabilities** | $8.29M | $4.61M | $14.07M | $12.12M | $3.99M | $2.22M | $1.45M | $17.52M | $1.36M | $1.77M |
| **Total Debt (incl. Leases)** | $274K | $456K | $243K | $79K | $161K | -- | -- | -- | -- | -- |
| Common Stock | $4.2K | $31K | $12K | $3.7K | $476K | $288K | $183K | $134K | $34K | $22K |
| Retained Earnings | -$186.9M | -$130.9M | -$104.4M | -$66.74M | -$47.26M | -$38.73M | -$32.17M | -$33.23M | -$14.03M | -$10.94M |
| **Total Stockholders' Equity** | $20.02M | $68.15M | -$2.13M | -$3.01M | $5.86M | $451K | $548K | -$15.56M | -$3.57M | -$2.91M |
| Total Equity | $20.02M | $68.15M | -$2.13M | -$3.01M | $5.86M | $451K | $548K | -$15.56M | -$3.57M | -$2.91M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.82M | $8.07M | $8.15M | $5.88M | $18.44M | $23.84M | $46.42M | $68.42M |
| Short-Term Investments | $0 | $2.00M | $8.96M | $19.85M | $16.87M | $24.75M | $12.80M | $0 |
| **Cash & Short-Term Investments** | $4.82M | $10.06M | $17.11M | $25.74M | $35.31M | $48.59M | $59.22M | $68.42M |
| Other Current Assets | $12K | $480K | $235K | $852K | $900K | $733K | $3.23M | $2.21M |
| **Total Current Assets** | $5.04M | $10.96M | $18.57M | $27.09M | $39.92M | $50.58M | $63.03M | $70.83M |
| Property, Plant & Equipment, Net | $20K | $33K | $756K | $899K | $1.03M | $1.17M | $1.30M | $1.43M |
| Other Non-Current Assets | $8.3K | $8.3K | $36K | $54K | $54K | $54K | $54K | $54K |
| **Total Non-Current Assets** | $37K | $75K | $850K | $1.22M | $1.40M | $1.58M | $1.77M | $1.94M |
| **Total Assets** | $5.07M | $11.03M | $19.42M | $28.31M | $41.32M | $52.16M | $64.79M | $72.76M |
| Accounts Payable | $2.45M | $4.28M | $3.94M | $2.03M | $2.83M | $3.22M | $1.71M | $569K |
| Other Current Liabilities | $1.08M | $966K | $3.35M | $2.64M | $2.37M | $2.22M | $848K | $654K |
| **Total Current Liabilities** | $3.71M | $11.53M | $10.40M | $8.21M | $8.37M | $8.31M | $5.32M | $4.34M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $84K | $120K | $172K | $223K | $273K |
| **Total Liabilities** | $3.71M | $11.53M | $10.40M | $8.29M | $8.49M | $8.48M | $5.54M | $4.61M |
| **Total Debt (incl. Leases)** | $9.5K | $36K | $61K | $274K | $322K | $368K | $412K | $456K |
| Common Stock | $4.4K | $35K | $35K | $4.2K | $31K | $31K | $31K | $31K |
| Retained Earnings | -$210.1M | -$210.2M | -$199.4M | -$186.9M | -$172.4M | -$159.7M | -$142.1M | -$130.9M |
| **Total Stockholders' Equity** | $1.36M | -$497K | $9.01M | $20.02M | $32.84M | $43.68M | $59.25M | $68.15M |
| Total Equity | $1.36M | -$497K | $9.01M | $20.02M | $32.84M | $43.68M | $59.25M | $68.15M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$55.92M | -$26.57M | -$37.64M | -$19.48M | -$8.52M | -$6.56M | $1.05M | -$19.19M | -$3.09M | -$3.18M |
| Depreciation & Amortization | $723K | $299K | $124K | $115K | $34K | $1.9K | $1.5K | $1.5K | $8.0K | $15K |
| Stock-Based Compensation | $7.77M | $8.32M | $988K | $629K | $869K | $303K | $680K | $675K | $609K | $706K |
| Change in Payables | $1.40M | -$587K | -$576K | $688K | $534K | $235K | $124K | -$85K | -$174K | $149K |
| **Operating Cash Flow** | -$43.06M | -$25.24M | -$13.95M | -$12.74M | -$6.47M | -$6.05M | -$6.03M | -$3.94M | -$3.33M | -$3.55M |
| Capital Expenditure | -$6.3K | -$1.60M | -$13K | -$28K | -$91K | -$7.2K | -- | -$4.4K | -$20K | -$11K |
| **Free Cash Flow** | -$43.07M | -$26.84M | -$13.96M | -$12.77M | -$6.57M | -$6.06M | -- | -$3.95M | -$3.35M | -$3.56M |
| **Investing Cash Flow** | -$19.50M | -$246K | $6.60M | $5.21M | -$91K | -$7.2K | -- | -$4.4K | -$20K | -$11K |
| Common Stock Issued | -- | $0 | $4.97M | $0 | $6.06M | $6.09M | $1.92M | $3.10M | -- | $408K |
| **Financing Cash Flow** | $30K | $83.56M | $16.44M | -$209K | $13.08M | $6.70M | $6.00M | $5.54M | $3.51M | $408K |
| **Net Change in Cash** | -$62.53M | $58.08M | $9.09M | -$7.74M | $6.51M | $639K | -$23K | $1.59M | $162K | -$3.16M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $69K | -$10.79M | -$12.51M | -$14.44M | -$12.75M | -$17.62M | -$11.10M | -$9.75M |
| Depreciation & Amortization | $31K | $158K | $173K | $180K | $179K | $187K | $177K | $175K |
| Stock-Based Compensation | $1.80M | $1.27M | $1.50M | $1.62M | $1.91M | $2.03M | $2.20M | $2.09M |
| Change in Payables | -$1.83M | $341K | $1.90M | -$792K | -$398K | $1.37M | $1.22M | -$211K |
| **Operating Cash Flow** | -$5.13M | -$7.12M | -$8.56M | -$9.77M | -$13.36M | -$10.75M | -$9.19M | -$8.17M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | -$6.3K | -$50K |
| **Free Cash Flow** | -$5.13M | -$7.12M | -$8.56M | -$9.77M | -$13.36M | -$10.75M | -$9.19M | -$8.22M |
| **Investing Cash Flow** | $2.00M | $7.14M | $10.90M | -$2.80M | $7.97M | -$11.86M | -$12.81M | $90K |
| **Financing Cash Flow** | -$117K | -$101K | -$72K | $11K | $0 | $18K | $0 | $5.6K |
| **Net Change in Cash** | -$3.25M | -$81K | $2.27M | -$12.56M | -$5.40M | -$22.58M | -$21.99M | -$8.08M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -279.3% | -39.0% | -- | -- | -145.3% | -1455.4% | 191.9% | -- | -- | -- |
| Return on Assets (ROA) | -197.5% | -36.5% | -315.3% | -213.8% | -86.5% | -245.6% | 52.7% | -980.7% | -555.3% | -982.8% |
| Current Ratio | 3.30x | 16.32x | 0.84x | 0.74x | 2.46x | 3.38x | 2.05x | 0.12x | 0.69x | 0.42x |
| Quick Ratio | 3.14x | 15.77x | 0.09x | 0.00x | 2.30x | 3.14x | 1.88x | 0.12x | 0.32x | 0.10x |
| Debt to Equity | 0.01x | 0.01x | -- | -- | 0.03x | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -723.7% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -400.0% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -137.4% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -2768.9% | -- | -636.2% | -279.3% | -156.0% | -97.0% | -55.1% | -39.0% |
| Return on Assets (ROA) | -742.6% | -457.6% | -295.3% | -197.5% | -124.0% | -81.2% | -50.4% | -36.5% |
| Current Ratio | 1.36x | 0.95x | 1.78x | 3.30x | 4.77x | 6.09x | 11.85x | 16.32x |
| Quick Ratio | 1.30x | 0.87x | 1.64x | 3.14x | 4.22x | 5.85x | 11.13x | 15.77x |
| Debt to Equity | 0.01x | -- | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
